05 April 2021

Champalimaud Foundation takes part in the initiative "Conversas com Cientistas - Décadas de Ciência para Dias de Vacinas"

This week, a national campaign on vaccines against COVID-19 was announced, involving several Portuguese scientific institutions. Sign up and join these conversations with scientists, which will take place between the 20th and the 30th of April.

"Conversations with Scientists"

One year after the COVID-19 pandemic started in Portugal, the campaign "Conversas com Cientistas - Décadas de Ciência para Dias de Vacinas" kicks off.

This joint initiative by Ciência Viva and several Portuguese scientific institutions, including the Champalimaud Foundation, will promote conversations between scientists and the general public on how the vaccines against COVID-19 were developed in record time, with effectiveness and safety guarantees. The mobilisation of the scientific community towards this campaign is yet another example of the collaborative efforts that have been taking place over the past year.

Between the 20th and the 30th of April, around 400 conversations will take place, at different times and aimed at different audiences - schools and organised groups of citizens, namely companies, associations and media, and individual citizens. To explore the decades of science that underlie the development of the vaccines against COVID-19, more than a hundred scientists and science communicators - from various fields of knowledge, working in more than two dozen institutions all over the country - will participate in this initiative.

Join these "Conversations with Scientists". Participation is free but prior registration is mandatory. All conversations will happen online, most will be held in Portuguese and some in English.

This campaign is the result of a partnership between Ciência Viva, Instituto de Investigação e Inovação em Saúde - Universidade do Porto (i3S), Sociedade Portuguesa de Imunologia (SPI) and COLife, an alliance between six Portuguese scientific institutions - Chronic Diseases Research Center - NOVA Medical School (CEDOC-NMS), Champalimaud Research - Champalimaud Foundation (CF), Instituto de Biologia Experimental e Tecnológica (iBET), Instituto de Medicina Molecular João Lobo Antunes (iMM), Instituto de Tecnologia Química e Biológica António Xavier - Universidade NOVA de Lisboa (ITQB NOVA) and Instituto Gulbenkian de Ciência (IGC).

Please wait...